第一单位：
Hepatitis B Foundation, Doylestown, Pennsylvania, United States of America.
作者：
Catherine,Freeland [1]
;
Florence,Kanu [2]
;
Yahaya,Mohammed [3]
;
Ugochukwu Uzoechina,Nwokoro [4]
;
Hardeep,Sandhu [4]
;
Hadley,Ikwe [5]
;
Belinda,Uba [2]
;
Adeyelu,Asekun [2]
;
Charles,Akataobi [6]
;
Adefisoye,Adewole [4]
;
Rhoda,Fadahunsi [7]
;
Margeret,Wisdom [2]
;
Okeke Lilian,Akudo [6]
;
Gideon,Ugbenyo [4]
;
Edwin,Simple [8]
;
Ndadilnasiya,Waziri [4]
;
James Jacob,Vasumu [8]
;
Abubakar Umar,Bahuli [4]
;
Suleiman Saidu,Bashir [8]
;
Abdullahi,Isa [4]
;
George Onyemachi,Ugwu [8]
;
Emmanuel Ikechukwu,Obi [4]
;
Haj,Binta [8]
;
Bassey Okposen,Bassey [4]
;
Faisal,Shuaib [8]
;
Omotayo,Bolu [4]
;
Rania A,Tohme [8]
作者单位：
Hepatitis B Foundation, Doylestown, Pennsylvania, United States of America.
[1]
Global Immunization Division, United States, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
[2]
Department of Medical Microbiology and Parasitology, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria.
[3]
African Field Epidemiology Network, Abuja, Nigeria.
[4]
Department of Community Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria.
[5]
Centers for Disease Control and Prevention Nigeria, Abuja, Nigeria.
[6]
National Emergency Routine Immunization Coordination Centre, Abuja, Nigeria.
[7]
National Stop Transmission of Poliomyelitis, Abuja, Nigeria.
[8]
Adamawa State Primary Health Care Development Agency, Yola, Adamawa State, Nigeria.
[9]
Department of Obstetrics and Gynaecology, College of Medicine, University of Nsukka, Nsukka, Nigeria.
[10]
Enugu State Primary Health Care Development Agency, Enugu, Nigeria.
[11]
Department of Community Medicine, Faculty of Medical Sciences, College of Medicine, University of Nigeria/ University of Nigeria Teaching Hospital, Enugu, Nigeria.
[12]
National Primary Health Care Development Agency, Abuja, Nigeria.
[13]
DOI
10.1371/journal.pgph.0001332
PMID
37289735
发布时间
2023-06-12
换一批
换一批
